bioAffinity Technologies, Inc. (BIAF NASDAQ) stock market data APIs
$2.4635
-0.02(-0.8%)
as of October 30, 2025
Try our APIs with
free plan!
bioAffinity Technologies, Inc. Financial Data Overview
Price chart is built with
Anychart
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Prev. Close
2.4635
Open
2.4442
High
2.5088
Low
2.3887
52 wk Range
2.3401-46.53
Market Cap
11 157 K
Shares Outstanding
4 499 K
Revenue
7 681 K
EPS
-0.17
Beta
2.342
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get bioAffinity Technologies, Inc. data using free add-ons & libraries
Get bioAffinity Technologies, Inc. Fundamental Data
bioAffinity Technologies, Inc. Fundamental data includes:
- Net Revenue: 7 681 K
- EBITDA: -9 490 369
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
bioAffinity Technologies, Inc. News
New
bioAffinity Technologies launches $1.8M direct financing
* bioAffinity Technologies (NASDAQ:BIAF [https://seekingalpha.com/symbol/BIAF]) has entered into definitive agreements for the purchase and sale of 720,000 shares of common stock, par value $0.007 p...
bioAffinity Technologies prices $4.8 million public offering; shares down over 30%
* bioAffinity Technologies (NASDAQ:BIAF [https://seekingalpha.com/symbol/BIAF]) announced on Monday that it has priced a public offering of securities for aggregate gross proceeds of $4.8 million, b...
bioAffinity Technologies announces 1-for-30 reverse stock split to regain Nasdaq compliance; shares down ~22%
* bioAffinity Technologies (NASDAQ:BIAF [https://seekingalpha.com/symbol/BIAF]) will implement a 1-for-30 reverse stock split effective at market open on September 19, 2025. * The reverse split re...
Tuesday's session: top gainers and losers
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT GORV [https://www.chartmill.com/...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
